Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 20.83B 3.11B 2.7B 2.56B 2.32B 4.34B 298B 4.37B 30.47B 11.78B 151B 11.68B 11.42B 485B P/E 2026 *
15.6x
P/E 2027 * 13.2x
Enterprise Value 19.28B 2.88B 2.5B 2.37B 2.15B 4.02B 276B 4.05B 28.21B 10.91B 140B 10.81B 10.58B 449B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.62x
Free-Float
47.11%
Yield 2026 *
2.79%
Yield 2027 * 3.38%
1 day+0.22%
1 week-3.13%
Current month-5.04%
1 month-9.07%
3 months-1.90%
6 months-2.52%
Current year-7.50%
1 week 13.78
Extreme 13.78
14.13
1 month 13.78
Extreme 13.78
15.61
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.5
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 08/05/2024
Director of Finance/CFO 49 09/07/2018
Chief Investment Officer 45 01/05/2025
Director TitleAgeSince
Director/Board Member 72 02/06/2021
Chairman 54 10/08/2026
Director/Board Member 58 08/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%-3.13% - - 3.1B
Average +0.22%
Weighted average by Cap. +0.22%

Financials

2026 *2027 *
Net sales 8.63B 1.29B 1.12B 1.06B 963M 1.8B 124B 1.81B 12.63B 4.88B 62.77B 4.84B 4.74B 201B 9.36B 1.4B 1.21B 1.15B 1.04B 1.95B 134B 1.97B 13.69B 5.29B 68.02B 5.25B 5.13B 218B
Net income 1.34B 200M 174M 164M 149M 279M 19.15B 281M 1.96B 756M 9.72B 750M 733M 31.14B 1.58B 236M 205M 194M 176M 330M 22.64B 332M 2.31B 894M 11.49B 886M 867M 36.8B
Net Debt -1.54B -231M -200M -190M -172M -322M -22.12B -324M -2.26B -873M -11.22B -866M -847M -35.95B -5.71B -853M -742M -702M -637M -1.19B -81.83B -1.2B -8.36B -3.23B -41.53B -3.2B -3.13B -133B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
17/09/26 CNY 13.94 +0.22% 6,716,801
16/09/26 CNY 13.91 -0.43% 8,974,200
15/09/26 CNY 13.97 -0.29% 7,749,311
14/09/26 CNY 14.01 -0.07% 11,466,726
11/09/26 CNY 14.02 -0.85% 21,057,925
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
13.94CNY
Average target price
17.29CNY
Spread / Average Target
+24.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!